Shield Therapeutics Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Millions GBP. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 18, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	68	105	21	52	18	96
Market Cap Growth	154.92%	395.31%	-59.70%	186.53%	-80.96%	28.62%
Enterprise Value	82	116	31	46	16	73
Last Close Price	0.06	0.10	0.03	0.07	0.07	0.43
PS Ratio	1.85	2.83	0.82	5.10	4.01	63.24
PB Ratio	-6.10	-9.34	-20.07	4.44	3.37	2.36
P/TBV Ratio	-	-	-	4.82	4.15	4.11
EV/Sales Ratio	2.22	3.15	1.19	4.50	3.48	48.36
Debt / Equity Ratio	-2.00	-2.00	-20.02	1.35	1.04	0.00
Net Debt / Equity Ratio	-1.23	-1.23	-15.07	0.42	0.52	-0.29
Net Debt / EBITDA Ratio	-1.88	-1.88	-0.89	-0.20	-0.11	0.64
Net Debt / FCF Ratio	-5.44	-5.44	-2.92	-0.17	-0.15	0.64
Asset Turnover	0.81	0.81	0.61	0.35	0.14	0.04
Inventory Turnover	3.59	3.59	3.89	3.65	1.63	0.65
Quick Ratio	0.67	0.67	0.90	1.83	0.62	3.73
Current Ratio	0.90	0.90	1.16	2.28	0.95	4.64
Return on Equity (ROE)	-	-	-396.36%	-308.60%	-179.19%	-55.46%
Return on Assets (ROA)	-10.24%	-10.24%	-26.90%	-51.93%	-49.37%	-32.97%
Return on Capital Employed (ROCE)	-66.70%	-66.70%	-92.00%	-89.40%	-229.50%	-49.90%
Earnings Yield	-19.18%	-12.54%	-102.83%	-49.88%	-225.97%	-20.48%
FCF Yield	-3.70%	-2.42%	-25.74%	-55.98%	-102.82%	-19.40%
Buyback Yield / Dilution	-33.81%	-33.81%	-8.33%	-209.85%	-14.08%	-74.36%